"Nik Gene O-gene" knowledge-based company Designing and producing molecular kits for early screening test to determine fetal sex, using a non-invasive method according to Real Time PCR analysis Objectives:
Clinical application of this technique is for pregnant women with X-linked recessive inheritance or those who are at risk for having a baby with Congenital adrenalhyperplasia.In such cases, for fetal determination that indicates a female fetus, non-invasive screens such as amniocenteses test is unnecessary and clinical management consultants for cases like Congenital AdrenalHyperplasia is provided. These kits are capable of diagnosing fetal sex, 8 weeks earlier than sonographic fetal gender determination. Technical explanation: fetal gender determination is done by taking mother's blood sample in first weeks of pregnancy which is considered as a clinical application for those pregnant women with X-linked recessive inheritance that is related to some diseases like Hemophilia, Duchenne and Becker muscular dystrophy, and so on; or those who are in risk of having a baby with Congenital AdrenalHyperplasia. In cases like that, for fetal determination that indicates a female fetus, non-invasive screens such as amniocenteses test is unnecessary and clinical management consultants for cases like Congenital AdrenalHyperplasia is provided. These kits are of great importance not only for clinical application as an early test determination of fetal gender, but also it is useful for parents who request for fetal gender determination.